Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

SMER28 attenuates PI3K/mTOR signaling by direct inhibition of PI3K p110 delta

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
7MB
[thumbnail of Supplementary Materials] Other (Supplementary Materials)
32MB

Item Type:Article
Title:SMER28 attenuates PI3K/mTOR signaling by direct inhibition of PI3K p110 delta
Creators Name:Kirchenwitz, M., Stahnke, S., Prettin, S., Borowiak, M., Menke, L., Sieben, C., Birchmeier, C., Rottner, K., Stradal, T.E.B. and Steffen, A.
Abstract:SMER28 (Small molecule enhancer of Rapamycin 28) is an autophagy-inducing compound functioning by a hitherto unknown mechanism. Here, we confirm its autophagy-inducing effect by assessing classical autophagy-related parameters. Interestingly, we also discovered several additional effects of SMER28, including growth retardation and reduced G1 to S phase progression. Most strikingly, SMER28 treatment led to a complete arrest of receptor tyrosine kinase signaling, and, consequently, growth factor-induced cell scattering and dorsal ruffle formation. This coincided with a dramatic reduction in phosphorylation patterns of PI3K downstream effectors. Consistently, SMER28 directly inhibited PI3Kδ and to a lesser extent p110γ. The biological relevance of our observations was underscored by SMER28 interfering with InlB-mediated host cell entry of Listeria monocytogenes, which requires signaling through the prominent receptor tyrosine kinase c-Met. This effect was signaling-specific, since entry of unrelated, gram-negative Salmonella Typhimurium was not inhibited. Lastly, in B cell lymphoma cells, which predominantly depend on tonic signaling through PI3Kδ, apoptosis upon SMER28 treatment is profound in comparison to non-hematopoietic cells. This indicates SMER28 as a possible drug candidate for the treatment of diseases that derive from aberrant PI3Kδ activity.
Keywords:Phosphatidylinositol 3-Kinase (PI 3-Kinase), Mammalian Target of Rapamycin (mTOR), Autophagy, Receptor Tyrosine Kinase, Small Molecule, Actin, Hepatocyte Growth Factor/Scatter Factor (HGF/SF), Platelet-Derived Growth Factor-C (PDGF-C), Cell Proliferation, Cancer Biology
Source:Cells
ISSN:2073-4409
Publisher:MDPI
Volume:11
Number:10
Page Range:1648
Date:16 May 2022
Official Publication:https://doi.org/10.3390/cells11101648
PubMed:View item in PubMed
Related to:

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library